@US10 silence since XanaHES announcement, page-205

Thanks Drifta. Twitter etc is just noise...best to focus on the fundamentals which is those previous results. They’ve highlighted further news going forward and what gives me confidence is that they always wanted to do a higher dosage trial 3 years ago but the FDA would only allow a10ml trial. Since then we have a new Chairman and and an exciting future which will be spelled out over the next few months, a globally New York recognized Biotech fund holding 20% and a bunch of Aussie short term funds that dumped the stock after investing in the capital raise at 5 cents for the 20ml trial, go figure?
The company got poleaxed by these Aussie insto’s that were bought up by speculators...stock price went 6 fold...they sold...stock retreated and found a base...I get it but I reckon nothing fundamental.
The company has globally recognized Directors, a World renowned Chairman and a Big Pharma CEO.
It has massive inflection points in the holy grail of biotech!